Target- |
MechanismCell replacements |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date06 Jul 2016 |
100 Clinical Results associated with ANC BIO INC
0 Patents (Medical) associated with ANC BIO INC
100 Deals associated with ANC BIO INC
100 Translational Medicine associated with ANC BIO INC